Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Acrux Ltd is an Australian pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. Its products include Testosterone Solution, Estradiol MDTS and others. It also has some of its products under the pipeline. Geographically, it has a presence in Australia; Germany; United States, and other countries. It generates maximum revenue from the Lenzetto product.
Melbourne, VIC, 3003, Australia